SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-033953
Filing Date
2020-10-29
Accepted
2020-10-29 15:59:40
Documents
21
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea129086-8k_lanternpharma.htm 8-K 22275
2 PRESS RELEASE DATED OCTOBER 29, 2020 ANNOUNCING FINANCIAL RESULTS FOR QUARTER EN ea129086ex99-1_lanternpharma.htm EX-99.1 61570
3 PRESENTATION RELATING TO OCTOBER 29, 2020 CONFERENCE CALL AND LIVE WEBCAST TO DI ea129086ex99-2_lanternpharma.htm EX-99.2 25285
4 GRAPHIC ex99-2_001.jpg GRAPHIC 259111
5 GRAPHIC ex99-2_002.jpg GRAPHIC 645690
6 GRAPHIC ex99-2_003.jpg GRAPHIC 212598
7 GRAPHIC ex99-2_004.jpg GRAPHIC 420595
8 GRAPHIC ex99-2_005.jpg GRAPHIC 286224
9 GRAPHIC ex99-2_006.jpg GRAPHIC 309719
10 GRAPHIC ex99-2_007.jpg GRAPHIC 244327
11 GRAPHIC ex99-2_008.jpg GRAPHIC 460629
12 GRAPHIC ex99-2_009.jpg GRAPHIC 321345
13 GRAPHIC ex99-2_010.jpg GRAPHIC 249757
14 GRAPHIC ex99-2_011.jpg GRAPHIC 118986
15 GRAPHIC ex99-2_012.jpg GRAPHIC 326112
16 GRAPHIC ex99-2_013.jpg GRAPHIC 402089
17 GRAPHIC ex99-2_014.jpg GRAPHIC 820136
18 GRAPHIC ex99-2_015.jpg GRAPHIC 422757
19 GRAPHIC ex99-2_016.jpg GRAPHIC 219553
20 GRAPHIC ex99-2_017.jpg GRAPHIC 152107
21 GRAPHIC ex99-1_001.jpg GRAPHIC 18593
  Complete submission text file 0001213900-20-033953.txt   8219911
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 201272563
SIC: 2834 Pharmaceutical Preparations